Page last updated: 2024-09-05

ahc 52 and n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine

ahc 52 has been researched along with n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine in 1 studies

Compound Research Comparison

Studies
(ahc 52)
Trials
(ahc 52)
Recent Studies (post-2010)
(ahc 52)
Studies
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Trials
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
700214558

Protein Interaction Comparison

ProteinTaxonomyahc 52 (IC50)n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine (IC50)
high affinity choline transporter 1 isoform aHomo sapiens (human)2.1002
Adenosine receptor A3Homo sapiens (human)0.0017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbracchio, MP; Jacobson, KA; Jiang, JL; Kim, YC; Sei, Y; Yao, Y1

Other Studies

1 other study(ies) available for ahc 52 and n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine

ArticleYear
Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists.
    Biochemical and biophysical research communications, 1997, Mar-17, Volume: 232, Issue:2

    Topics: Adenosine; Apoptosis; Dihydropyridines; DNA Fragmentation; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrazoles; Quinazolines; Triazoles

1997